$NEPH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEPHROS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NEPHROS INC. Get notifications about new insider transactions in NEPHROS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 25 2021 | NEPH | NEPHROS INC | Evans Daron | CEO of Specialty Re ... | Option Exercise | X | 2.70 | 1,111 | 3,000 | 0 | |
May 25 2021 | NEPH | NEPHROS INC | Evans Daron | CEO of Specialty Re ... | Option Exercise | X | 2.70 | 1,111 | 3,000 | 0 | |
May 25 2021 | NEPH | NEPHROS INC | Evans Daron | CEO of Specialty Re ... | Buy | X | 2.70 | 1,111 | 3,000 | 9,018 | 7.9 K to 9 K (+14.05 %) |
May 25 2021 | NEPH | NEPHROS INC | Evans Daron | CEO of Specialty Re ... | Buy | X | 2.70 | 1,111 | 3,000 | 9,296 | 8.2 K to 9.3 K (+13.57 %) |
Feb 18 2021 | NEPH | NEPHROS INC | Lobo Wesley S. | Chief Marketing Off ... | Option Exercise | A | 8.66 | 114,178 | 988,781 | 114,178 | |
Feb 18 2021 | NEPH | NEPHROS INC | Lobo Wesley S. | Chief Marketing Off ... | Grant | A | 0.00 | 40,557 | 0 | 40,557 | 0 to 40.6 K |
Jan 29 2021 | NEPH | NEPHROS INC | WEXFORD CAPITAL LP | Option Exercise | M | 4.50 | 4,477 | 20,147 | 4,477 | ||
Jan 29 2021 | NEPH | NEPHROS INC | WEXFORD CAPITAL LP | Option Exercise | M | 3.60 | 3,765 | 13,554 | 3,765 | ||
Jan 29 2021 | NEPH | NEPHROS INC | WEXFORD CAPITAL LP | Option Exercise | M | 4.14 | 2,956 | 12,238 | 2,956 | ||
Jan 29 2021 | NEPH | NEPHROS INC | WEXFORD CAPITAL LP | Option Exercise | M | 4.59 | 3,556 | 16,322 | 3,556 | ||
Jan 29 2021 | NEPH | NEPHROS INC | WEXFORD CAPITAL LP | Option Exercise | M | 4.50 | 4,477 | 20,147 | 4,477 | ||
Jan 29 2021 | NEPH | NEPHROS INC | WEXFORD CAPITAL LP | Buy | M | 4.50 | 4,477 | 20,147 | 106,037 | 101.6 K to 106 K (+4.41 %) | |
Jan 29 2021 | NEPH | NEPHROS INC | WEXFORD CAPITAL LP | Option Exercise | M | 3.60 | 3,765 | 13,554 | 3,765 | ||
Jan 29 2021 | NEPH | NEPHROS INC | WEXFORD CAPITAL LP | Buy | M | 3.60 | 3,765 | 13,554 | 101,560 | 97.8 K to 101.6 K (+3.85 %) | |
Jan 29 2021 | NEPH | NEPHROS INC | WEXFORD CAPITAL LP | Option Exercise | M | 4.14 | 2,956 | 12,238 | 2,956 | ||
Jan 29 2021 | NEPH | NEPHROS INC | WEXFORD CAPITAL LP | Buy | M | 4.14 | 2,956 | 12,238 | 97,795 | 94.8 K to 97.8 K (+3.12 %) | |
Jan 29 2021 | NEPH | NEPHROS INC | WEXFORD CAPITAL LP | Option Exercise | M | 4.59 | 3,556 | 16,322 | 3,556 | ||
Jan 29 2021 | NEPH | NEPHROS INC | WEXFORD CAPITAL LP | Buy | M | 4.59 | 3,556 | 16,322 | 94,839 | 91.3 K to 94.8 K (+3.90 %) | |
Jan 29 2021 | NEPH | NEPHROS INC | WEXFORD CAPITAL LP | Buy | M | 4.50 | 4,477 | 20,147 | 106,037 | 101.6 K to 106 K (+4.41 %) | |
Jan 29 2021 | NEPH | NEPHROS INC | WEXFORD CAPITAL LP | Buy | M | 3.60 | 3,765 | 13,554 | 101,560 | 97.8 K to 101.6 K (+3.85 %) | |
Jan 29 2021 | NEPH | NEPHROS INC | WEXFORD CAPITAL LP | Buy | M | 4.14 | 2,956 | 12,238 | 97,795 | 94.8 K to 97.8 K (+3.12 %) | |
Jan 29 2021 | NEPH | NEPHROS INC | WEXFORD CAPITAL LP | Buy | M | 4.59 | 3,556 | 16,322 | 94,839 | 91.3 K to 94.8 K (+3.90 %) | |
Jan 08 2021 | NEPH | NEPHROS INC | WEXFORD CAPITAL LP | Grant | A | 0.00 | 3,196 | 0 | 3,196 | 0 to 3.2 K | |
Jan 08 2021 | NEPH | NEPHROS INC | Gwydir Tom | Director | Option Exercise | A | 8.06 | 6,850 | 55,211 | 6,850 | |
Jan 08 2021 | NEPH | NEPHROS INC | Gwydir Tom | Director | Grant | A | 0.00 | 3,666 | 0 | 6,031 | 2.4 K to 6 K (+155.01 %) |
Jan 08 2021 | NEPH | NEPHROS INC | Lask Alisa | Director | Option Exercise | A | 8.06 | 6,850 | 55,211 | 6,850 | |
Jan 08 2021 | NEPH | NEPHROS INC | Lask Alisa | Director | Grant | A | 0.00 | 3,666 | 0 | 7,143 | 3.5 K to 7.1 K (+105.44 %) |
Jan 08 2021 | NEPH | NEPHROS INC | PERSEN MALCOLM C | Director | Option Exercise | A | 8.06 | 6,850 | 55,211 | 6,850 | |
Jan 08 2021 | NEPH | NEPHROS INC | PERSEN MALCOLM C | Director | Grant | A | 0.00 | 5,921 | 0 | 48,774 | 42.9 K to 48.8 K (+13.82 %) |
Jan 08 2021 | NEPH | NEPHROS INC | Spandow Oliver J. | Director | Option Exercise | A | 8.06 | 6,850 | 55,211 | 6,850 | |
Jan 08 2021 | NEPH | NEPHROS INC | Spandow Oliver J. | Director | Grant | A | 0.00 | 3,666 | 0 | 19,400 | 15.7 K to 19.4 K (+23.30 %) |
Jan 08 2021 | NEPH | NEPHROS INC | AMRON ARTHUR H | Director | Option Exercise | A | 8.06 | 6,850 | 55,211 | 6,850 | |
Jan 08 2021 | NEPH | NEPHROS INC | AMRON ARTHUR H | Director | Grant | A | 0.00 | 3,666 | 0 | 3,666 | 0 to 3.7 K |
Nov 20 2020 | NEPH | NEPHROS INC | Spandow Oliver J. | Director | Buy | P | 5.83 | 1,500 | 8,749 | 15,734 | 14.2 K to 15.7 K (+10.54 %) |
Nov 19 2020 | NEPH | NEPHROS INC | Astor Andrew | President & CEO | Buy | P | 5.87 | 1,000 | 5,867 | 72,958 | 72 K to 73 K (+1.39 %) |
Oct 16 2020 | NEPH | NEPHROS INC | WEXFORD CAPITAL LP | Grant | A | 6.00 | 166,667 | 1,000,002 | 3,605,471 | 3.4 M to 3.6 M (+4.85 %) | |
Aug 26 2020 | NEPH | NEPHROS INC | Astor Andrew | President/CEO/CFO | Option Exercise | A | 7.07 | 152,064 | 1,075,092 | 152,064 | |
Aug 19 2020 | NEPH | NEPHROS INC | Astor Andrew | COO/CFO | Buy | P | 7.40 | 950 | 7,030 | 71,958 | 71 K to 72 K (+1.34 %) |
May 29 2020 | NEPH | NEPHROS INC | Astor Andrew | CFO/COO | Buy | P | 6.96 | 1,000 | 6,960 | 71,008 | 70 K to 71 K (+1.43 %) |
May 13 2020 | NEPH | NEPHROS INC | PERSEN MALCOLM C | Director | Option Exercise | X | 7.65 | 1,732 | 13,250 | 0 | |
May 13 2020 | NEPH | NEPHROS INC | PERSEN MALCOLM C | Director | Buy | X | 7.65 | 1,732 | 13,250 | 5,194 | 3.5 K to 5.2 K (+50.03 %) |
Mar 12 2020 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Buy | P | 6.65 | 2,500 | 16,625 | 134,215 | 131.7 K to 134.2 K (+1.90 %) |
Mar 12 2020 | NEPH | NEPHROS INC | Astor Andrew | CFO/COO | Buy | P | 6.70 | 1,000 | 6,700 | 70,008 | 69 K to 70 K (+1.45 %) |
Mar 12 2020 | NEPH | NEPHROS INC | Astor Andrew | CFO/COO | Buy | P | 6.70 | 1,000 | 6,700 | 70,008 | 69 K to 70 K (+1.45 %) |
Mar 05 2020 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Buy | P | 8.44 | 2,500 | 21,109 | 131,715 | 129.2 K to 131.7 K (+1.93 %) |
Mar 05 2020 | NEPH | NEPHROS INC | Astor Andrew | CFO/COO | Buy | P | 8.46 | 700 | 5,920 | 69,008 | 68.3 K to 69 K (+1.02 %) |
Feb 05 2020 | NEPH | NEPHROS INC | Astor Andrew | CFO/COO | Option Exercise | A | 2.64 | 13,958 | 36,849 | 46,525 | |
Feb 05 2020 | NEPH | NEPHROS INC | Astor Andrew | CFO/COO | Option Exercise | A | 4.14 | 19,320 | 79,985 | 64,399 | |
Feb 05 2020 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Option Exercise | A | 5.40 | 97,076 | 524,210 | 242,690 | |
Dec 18 2019 | NEPH | NEPHROS INC | Astor Andrew | CFO/COO | Option Exercise | A | 8.30 | 20,000 | 166,000 | 20,000 | |
Dec 18 2019 | NEPH | NEPHROS INC | Astor Andrew | CFO/COO | Grant | A | 0.00 | 6,848 | 0 | 68,308 | 61.5 K to 68.3 K (+11.14 %) |
Dec 18 2019 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Option Exercise | A | 8.57 | 20,000 | 171,400 | 20,000 | |
Dec 18 2019 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Grant | A | 0.00 | 9,282 | 0 | 129,215 | 119.9 K to 129.2 K (+7.74 %) |
Dec 18 2019 | NEPH | NEPHROS INC | Lask Alisa | Director | Option Exercise | A | 8.57 | 5,568 | 47,718 | 5,568 | |
Dec 18 2019 | NEPH | NEPHROS INC | Lask Alisa | Director | Grant | A | 0.00 | 3,227 | 0 | 3,477 | 250 to 3.5 K (+1,290.80 %) |
Dec 18 2019 | NEPH | NEPHROS INC | Spandow Oliver J. | Director | Option Exercise | A | 8.57 | 5,568 | 47,718 | 5,568 | |
Dec 18 2019 | NEPH | NEPHROS INC | Spandow Oliver J. | Director | Grant | A | 0.00 | 3,448 | 0 | 14,234 | 10.8 K to 14.2 K (+31.97 %) |
Dec 18 2019 | NEPH | NEPHROS INC | Gwydir Tom | Director | Option Exercise | A | 8.57 | 5,568 | 47,718 | 5,568 | |
Dec 18 2019 | NEPH | NEPHROS INC | Gwydir Tom | Director | Grant | A | 0.00 | 2,365 | 0 | 2,365 | 0 to 2.4 K |
Dec 18 2019 | NEPH | NEPHROS INC | PERSEN MALCOLM C | Director | Option Exercise | A | 8.57 | 5,568 | 47,718 | 5,568 | |
Dec 18 2019 | NEPH | NEPHROS INC | PERSEN MALCOLM C | Director | Grant | A | 0.00 | 5,437 | 0 | 42,853 | 37.4 K to 42.9 K (+14.53 %) |
Dec 18 2019 | NEPH | NEPHROS INC | AMRON ARTHUR H | Director | Option Exercise | A | 8.57 | 5,568 | 47,718 | 5,568 | |
Dec 18 2019 | NEPH | NEPHROS INC | AMRON ARTHUR H | Director | Grant | A | 0.00 | 3,448 | 0 | 3,448 | 0 to 3.4 K |
Dec 18 2019 | NEPH | NEPHROS INC | Mieyal Paul A | Director | Option Exercise | A | 8.57 | 5,568 | 47,718 | 5,568 | |
Dec 18 2019 | NEPH | NEPHROS INC | Mieyal Paul A | Director | Grant | A | 0.00 | 3,448 | 0 | 3,448 | 0 to 3.4 K |
Nov 26 2019 | NEPH | NEPHROS INC | Spandow Oliver J. | Director | Buy | P | 8.17 | 1,000 | 8,170 | 10,786 | 9.8 K to 10.8 K (+10.22 %) |
Nov 18 2019 | NEPH | NEPHROS INC | Astor Andrew | CFO/COO | Buy | P | 8.38 | 750 | 6,282 | 61,460 | 60.7 K to 61.5 K (+1.24 %) |
Nov 18 2019 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Buy | P | 8.35 | 1,000 | 8,350 | 119,933 | 118.9 K to 119.9 K (+0.84 %) |
Sep 13 2019 | NEPH | NEPHROS INC | Lask Alisa | Director | Buy | P | 6.45 | 250 | 1,613 | 250 | 0 to 250 |
Aug 22 2019 | NEPH | NEPHROS INC | Astor Andrew | CFO/COO | Buy | P | 6.97 | 1,500 | 10,455 | 60,710 | 59.2 K to 60.7 K (+2.53 %) |
Aug 22 2019 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Buy | P | 6.92 | 2,000 | 13,845 | 118,933 | 116.9 K to 118.9 K (+1.71 %) |
Aug 13 2019 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Option Exercise | A | 5.40 | 36,404 | 196,582 | 145,614 | |
Aug 13 2019 | NEPH | NEPHROS INC | Astor Andrew | CFO/COO | Option Exercise | A | 2.64 | 9,305 | 24,565 | 32,567 | |
Aug 13 2019 | NEPH | NEPHROS INC | Astor Andrew | CFO/COO | Option Exercise | A | 4.14 | 12,880 | 53,323 | 45,079 | |
Jun 14 2019 | NEPH | NEPHROS INC | Astor Andrew | CFO/COO | Buy | P | 0.64 | 35,000 | 22,400 | 532,903 | 497.9 K to 532.9 K (+7.03 %) |
Jun 14 2019 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Buy | P | 0.60 | 8,000 | 4,830 | 8,000 | 0 to 8 K |
Jun 14 2019 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Buy | P | 0.61 | 8,000 | 4,875 | 8,000 | 0 to 8 K |
Jun 14 2019 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Buy | P | 0.59 | 8,000 | 4,720 | 71,166 | 63.2 K to 71.2 K (+12.67 %) |
Jun 14 2019 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Buy | P | 0.58 | 8,000 | 4,653 | 73,666 | 65.7 K to 73.7 K (+12.18 %) |
Jun 14 2019 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Buy | P | 0.60 | 11,172 | 6,683 | 1,052,426 | 1 M to 1.1 M (+1.07 %) |
May 01 2019 | NEPH | NEPHROS INC | Gwydir Tom | Director | Option Exercise | A | 0.59 | 86,641 | 51,118 | 86,641 | |
May 01 2019 | NEPH | NEPHROS INC | Gwydir Tom | Director | Option Exercise | A | 0.59 | 86,641 | 51,118 | 86,641 | |
Feb 12 2019 | NEPH | NEPHROS INC | Lask Alisa | Director | Option Exercise | A | 0.58 | 70,817 | 41,074 | 70,817 | |
Dec 21 2018 | NEPH | NEPHROS INC | AMRON ARTHUR H | Director | Option Exercise | A | 0.65 | 46,457 | 30,197 | 46,457 | |
Dec 21 2018 | NEPH | NEPHROS INC | Astor Andrew | CFO/COO | Option Exercise | A | 0.65 | 200,000 | 130,000 | 200,000 | |
Dec 21 2018 | NEPH | NEPHROS INC | Mieyal Paul A | Director | Option Exercise | A | 0.65 | 46,457 | 30,197 | 46,457 | |
Dec 21 2018 | NEPH | NEPHROS INC | PERSEN MALCOLM C | Director | Option Exercise | A | 0.65 | 46,457 | 30,197 | 46,457 | |
Dec 21 2018 | NEPH | NEPHROS INC | Pinto Moshe | Director | Option Exercise | A | 0.65 | 46,457 | 30,197 | 46,457 | |
Dec 21 2018 | NEPH | NEPHROS INC | Spandow Oliver J. | Director | Option Exercise | A | 0.65 | 46,457 | 30,197 | 46,457 | |
Dec 18 2018 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Grant | A | 0.00 | 108,296 | 0 | 1,001,254 | 893 K to 1 M (+12.13 %) |
Dec 18 2018 | NEPH | NEPHROS INC | Astor Andrew | Chief Financial Off ... | Grant | A | 0.00 | 44,111 | 0 | 497,903 | 453.8 K to 497.9 K (+9.72 %) |
Dec 18 2018 | NEPH | NEPHROS INC | PERSEN MALCOLM C | Director | Grant | A | 0.00 | 71,509 | 0 | 336,750 | 265.2 K to 336.8 K (+26.96 %) |
Dec 18 2018 | NEPH | NEPHROS INC | Pinto Moshe | Director | Grant | A | 0.00 | 73,343 | 0 | 229,788 | 156.4 K to 229.8 K (+46.88 %) |
Dec 18 2018 | NEPH | NEPHROS INC | Spandow Oliver J. | Director | Grant | A | 0.00 | 18,030 | 0 | 88,080 | 70.1 K to 88.1 K (+25.74 %) |
Dec 18 2018 | NEPH | NEPHROS INC | AMRON ARTHUR H | Director | Grant | A | 0.00 | 47,673 | 0 | 47,673 | 0 to 47.7 K |
Dec 18 2018 | NEPH | NEPHROS INC | Mieyal Paul A | Director | Grant | A | 0.00 | 47,673 | 0 | 47,673 | 0 to 47.7 K |
Aug 13 2018 | NEPH | NEPHROS INC | Spandow Oliver J. | Director | Option Exercise | A | 0.62 | 85,199 | 52,781 | 85,199 | |
May 14 2018 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Option Exercise | X | 0.30 | 40,000 | 12,000 | 0 | |
May 14 2018 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Buy | X | 0.30 | 40,000 | 12,000 | 95,000 | 55 K to 95 K (+72.73 %) |
Apr 12 2018 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Buy | P | 0.45 | 12,000 | 5,400 | 63,166 | 51.2 K to 63.2 K (+23.45 %) |
Apr 12 2018 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Buy | P | 0.45 | 12,000 | 5,400 | 65,666 | 53.7 K to 65.7 K (+22.36 %) |
Apr 12 2018 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Buy | P | 0.45 | 55,000 | 24,750 | 55,000 | 0 to 55 K |
Apr 12 2018 | NEPH | NEPHROS INC | Astor Andrew | Chief Financial Off ... | Buy | P | 0.45 | 80,000 | 36,000 | 420,459 | 340.5 K to 420.5 K (+23.50 %) |
Mar 13 2018 | NEPH | NEPHROS INC | Astor Andrew | Chief Financial Off ... | Buy | P | 0.48 | 5,000 | 2,375 | 340,459 | 335.5 K to 340.5 K (+1.49 %) |
Feb 22 2018 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Option Exercise | A | 0.60 | 218,419 | 131,051 | 982,887 | |
Dec 22 2017 | NEPH | NEPHROS INC | AMRON ARTHUR H | Director | Option Exercise | A | 0.50 | 40,284 | 20,138 | 40,284 | |
Dec 22 2017 | NEPH | NEPHROS INC | AMRON ARTHUR H | Director | Grant | A | 0.00 | 73,864 | 0 | 73,864 | 0 to 73.9 K |
Dec 22 2017 | NEPH | NEPHROS INC | Mieyal Paul A | Director | Option Exercise | A | 0.50 | 40,284 | 20,138 | 40,284 | |
Dec 22 2017 | NEPH | NEPHROS INC | Mieyal Paul A | Director | Grant | A | 0.00 | 73,864 | 0 | 73,864 | 0 to 73.9 K |
Dec 22 2017 | NEPH | NEPHROS INC | PERSEN MALCOLM C | Director | Option Exercise | A | 0.50 | 40,284 | 20,138 | 40,284 | |
Dec 22 2017 | NEPH | NEPHROS INC | PERSEN MALCOLM C | Director | Grant | A | 0.00 | 113,636 | 0 | 265,241 | 151.6 K to 265.2 K (+74.96 %) |
Dec 22 2017 | NEPH | NEPHROS INC | Pinto Moshe | Director | Option Exercise | A | 0.50 | 40,284 | 20,138 | 40,284 | |
Dec 22 2017 | NEPH | NEPHROS INC | Pinto Moshe | Director | Grant | A | 0.00 | 73,864 | 0 | 156,445 | 82.6 K to 156.4 K (+89.44 %) |
Dec 22 2017 | NEPH | NEPHROS INC | Astor Andrew | Chief Financial Off ... | Option Exercise | A | 0.50 | 50,000 | 24,995 | 50,000 | |
Dec 22 2017 | NEPH | NEPHROS INC | Astor Andrew | Chief Financial Off ... | Grant | A | 0.00 | 120,417 | 0 | 335,459 | 215 K to 335.5 K (+56.00 %) |
Dec 22 2017 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Option Exercise | A | 0.50 | 837,125 | 418,479 | 837,125 | |
Dec 22 2017 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Grant | A | 0.00 | 180,000 | 0 | 892,958 | 713 K to 893 K (+25.25 %) |
Dec 05 2017 | NEPH | NEPHROS INC | Astor Andrew | Chief Financial Off ... | Buy | P | 0.50 | 8,333 | 4,167 | 215,042 | 206.7 K to 215 K (+4.03 %) |
Dec 05 2017 | NEPH | NEPHROS INC | Astor Andrew | Chief Financial Off ... | Buy | P | 0.50 | 10,000 | 5,000 | 206,709 | 196.7 K to 206.7 K (+5.08 %) |
Sep 06 2017 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Buy | P | 0.24 | 28,000 | 6,818 | 712,958 | 685 K to 713 K (+4.09 %) |
Sep 06 2017 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Buy | P | 0.24 | 1,580 | 371 | 684,958 | 683.4 K to 685 K (+0.23 %) |
Aug 28 2017 | NEPH | NEPHROS INC | Astor Andrew | Chief Financial Off ... | Buy | P | 0.27 | 4,000 | 1,092 | 196,709 | 192.7 K to 196.7 K (+2.08 %) |
Aug 28 2017 | NEPH | NEPHROS INC | Astor Andrew | Chief Financial Off ... | Buy | P | 0.27 | 6,000 | 1,620 | 192,709 | 186.7 K to 192.7 K (+3.21 %) |
Aug 28 2017 | NEPH | NEPHROS INC | Astor Andrew | Chief Financial Off ... | Buy | L | 0.27 | 43 | 11 | 186,709 | 186.7 K to 186.7 K (+0.02 %) |
Aug 23 2017 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Buy | P | 0.25 | 2,000 | 500 | 51,166 | 49.2 K to 51.2 K (+4.07 %) |
Aug 23 2017 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Buy | P | 0.25 | 2,000 | 500 | 53,666 | 51.7 K to 53.7 K (+3.87 %) |
Aug 11 2017 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Buy | P | 0.26 | 70,000 | 18,200 | 683,378 | 613.4 K to 683.4 K (+11.41 %) |
Aug 11 2017 | NEPH | NEPHROS INC | Astor Andrew | Chief Financial Off ... | Buy | P | 0.26 | 20,000 | 5,198 | 186,666 | 166.7 K to 186.7 K (+12.00 %) |
May 19 2017 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Buy | P | 0.26 | 7,500 | 1,913 | 609,417 | 601.9 K to 609.4 K (+1.25 %) |
May 19 2017 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Buy | P | 0.26 | 22,500 | 5,738 | 601,917 | 579.4 K to 601.9 K (+3.88 %) |
May 02 2017 | NEPH | NEPHROS INC | Astor Andrew | Chief Financial Off ... | Option Exercise | A | 0.29 | 209,355 | 61,341 | 209,355 | |
Apr 04 2017 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Grant | A | 0.00 | 17,756 | 0 | 579,417 | 561.7 K to 579.4 K (+3.16 %) |
Mar 21 2017 | NEPH | NEPHROS INC | Astor Andrew | Chief Financial Off ... | Option Exercise | P | 0.30 | 166,666 | 50,000 | 166,666 | |
Mar 21 2017 | NEPH | NEPHROS INC | Astor Andrew | Chief Financial Off ... | Buy | P | 0.00 | 166,666 | 0 | 166,666 | 0 to 166.7 K |
Mar 21 2017 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Option Exercise | P | 0.30 | 41,666 | 12,500 | 41,666 | |
Mar 21 2017 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Option Exercise | P | 0.30 | 41,666 | 12,500 | 41,666 | |
Mar 21 2017 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Buy | P | 0.00 | 41,666 | 0 | 41,666 | 0 to 41.7 K |
Mar 21 2017 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Buy | P | 0.00 | 41,666 | 0 | 41,666 | 0 to 41.7 K |
Feb 15 2017 | NEPH | NEPHROS INC | Astor Andrew | Chief Financial Off ... | Option Exercise | A | 0.46 | 289,785 | 133,272 | 289,785 | |
Dec 23 2016 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Grant | A | 0.00 | 213,068 | 0 | 561,661 | 348.6 K to 561.7 K (+61.12 %) |
Dec 15 2016 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Grant | A | 0.00 | 9,165 | 0 | 348,593 | 339.4 K to 348.6 K (+2.70 %) |
Dec 09 2016 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Buy | P | 0.32 | 4,069 | 1,302 | 339,428 | 335.4 K to 339.4 K (+1.21 %) |
Dec 06 2016 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Buy | P | 0.34 | 6,020 | 2,047 | 335,359 | 329.3 K to 335.4 K (+1.83 %) |
Dec 06 2016 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Buy | P | 0.34 | 4,600 | 1,564 | 329,339 | 324.7 K to 329.3 K (+1.42 %) |
Dec 02 2016 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Buy | P | 0.32 | 40,599 | 13,016 | 324,739 | 284.1 K to 324.7 K (+14.29 %) |
Dec 02 2016 | NEPH | NEPHROS INC | Evans Daron | President and CEO | Buy | P | 0.29 | 931 | 270 | 284,140 | 283.2 K to 284.1 K (+0.33 %) |
Aug 26 2016 | NEPH | NEPHROS INC | Pinto Moshe | Director | Option Exercise | A | 0.40 | 33,880 | 13,552 | 33,880 | |
Aug 26 2016 | NEPH | NEPHROS INC | Pinto Moshe | Director | Grant | A | 0.00 | 73,864 | 0 | 82,581 | 8.7 K to 82.6 K (+847.36 %) |
Aug 26 2016 | NEPH | NEPHROS INC | PERSEN MALCOLM C | Director | Option Exercise | A | 0.40 | 33,880 | 13,552 | 33,880 | |
Aug 26 2016 | NEPH | NEPHROS INC | PERSEN MALCOLM C | Director | Grant | A | 0.00 | 113,636 | 0 | 151,605 | 38 K to 151.6 K (+299.29 %) |